Intranasal Ketamine as a Sedative for Venipuncture

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Respiratory Tract DiseaseAcute PainDiseases of the Digestive System
Interventions
DRUG

Ketamine

As indicated the use of sedative and after authorization of the person responsible, the child receives the intranasal solution. Before administration of the solution 2 hour and 24 hours after the procedure, must be recorded vital signs of the patient. A person with the help of a clock will make the time count. The nurse and the patient's family must respond to the study protocol questions

DRUG

Placebo

As indicated the use of sedative and after authorization of the person responsible, the child receives the intranasal solution. Before administration of the solution 2 hour and 24 hours after the procedure, must be recorded vital signs of the patient. A person with the help of a clock will make the time count. The nurse and the patient's family must respond to the study protocol questions

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02929524 - Intranasal Ketamine as a Sedative for Venipuncture | Biotech Hunter | Biotech Hunter